Proteobacteria: microbial signature of dysbiosis in gut microbiota.
By N. Shin, T. Whon, Jin-Woo Bae. Trends in Biotechnology, 2015
3,363 citations recorded by the source corpus.
Subfields: Molecular Biology, Periodontics, Rheumatology
View Paper: https://www.semanticscholar.org/paper/e20344ccff906bafafe5ed56264dfaaabc19593f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Reshaping gut bacterial communities after dietary Tenebrio molitor larvae meal supplementation in three fish species (2019, positive): “In the human gut, for example, the dominance of Proteobacteria vs. Firmicutes and/or Bacteroidetes has been suggested to be an indication of gut dysbiosis (Shin et al. 2015).”
- Proteobacteria: A Common Factor in Human Diseases (2017, background): “Based on these data, authors have proposed that Proteobacteria may represent a “microbial signature” of disease [50].”
- Intestinal microbiota of healthy and unhealthy Atlantic salmon Salmo salar L. in a recirculating aquaculture system (2018, background): “In many cases, pathogens, such as Vibrio , are opportunistic and only cause disease when the host is under immune or physiological stress (Sommer and Bäckhed, 2013).”
- Microbiota-activated PPAR-γ-signaling inhibits dysbiotic Enterobacteriaceae expansion (2017, positive): “A balanced gut microbiota is characterized by the dominance of obligate anaerobic members of the phyla Firmicutes and Bacteroidetes, while an expansion of facultative anaerobic Enterobacteriaceae (phylum Proteobacteria) is a common marker of gut dysbiosis (1) (Fig.”
- Bifidobacteria-mediated immune system imprinting early in life (2020, background): “Indeed, multiple studies have emphasized how early gut microbiome dysbiosis, described as an overabundance of proteobacteria (Shin et al., 2015) and loss of ecosystem function (Duar et al.”
- The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease (2020, background): “The most variable phylum was demonstrated to be Proteobacteria, which contributes to dysbiosis [11] and is correlated with a decrease in Firmicutes and general microbial diversity in inflammatory bowel disease (IBD) [12].”